BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1388649)

  • 1. NK cells and T cells: mirror images?
    Versteeg R
    Immunol Today; 1992 Jul; 13(7):244-7. PubMed ID: 1388649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC gene control of the natural killer system at the level of the target and the host.
    Kärre K
    Semin Cancer Biol; 1991 Oct; 2(5):295-309. PubMed ID: 1773046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
    Kumar V; McNerney ME
    Nat Rev Immunol; 2005 May; 5(5):363-74. PubMed ID: 15841099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host MHC class I molecules modulate in vivo expression of a NK cell receptor.
    Karlhofer FM; Hunziker R; Reichlin A; Margulies DH; Yokoyama WM
    J Immunol; 1994 Sep; 153(6):2407-16. PubMed ID: 8077656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cells can recognize different forms of class I MHC.
    Su RC; Kung SK; Gariépy J; Barber BH; Miller RG
    J Immunol; 1998 Jul; 161(2):755-66. PubMed ID: 9670952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of class I MHC binding peptides on recognition by natural killer cells.
    Chadwick BS; Sambhara SR; Sasakura Y; Miller RG
    J Immunol; 1992 Nov; 149(10):3150-6. PubMed ID: 1431094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of inhibitory receptors for MHC class I molecules on T cells.
    Huard B
    Crit Rev Immunol; 2000; 20(6):471-6. PubMed ID: 11396682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the complexity of self.
    Rudensky AYu ; Rath S; Preston-Hurlburt P; Murphy DB; Janeway CA
    Nature; 1991 Oct; 353(6345):660-2. PubMed ID: 1656278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
    Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells.
    Held W; Roland J; Raulet DH
    Nature; 1995 Jul; 376(6538):355-8. PubMed ID: 7630404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human NK cell education by inhibitory receptors for MHC class I.
    Anfossi N; André P; Guia S; Falk CS; Roetynck S; Stewart CA; Breso V; Frassati C; Reviron D; Middleton D; Romagné F; Ugolini S; Vivier E
    Immunity; 2006 Aug; 25(2):331-42. PubMed ID: 16901727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ly49A allelic variation and MHC class I specificity.
    Mehta IK; Wang J; Roland J; Margulies DH; Yokoyama WM
    Immunogenetics; 2001 Sep; 53(7):572-83. PubMed ID: 11685470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells.
    Correa I; Corral L; Raulet DH
    Eur J Immunol; 1994 Jun; 24(6):1323-31. PubMed ID: 8206092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Karlhofer FM; Ribaudo RK; Yokoyama WM
    Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of selection of NK-T cells in the thymus].
    Tsuchida K
    Hokkaido Igaku Zasshi; 1995 May; 70(3):437-44. PubMed ID: 7590595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of glycosylphosphatidylinositol-linked H-2Dd molecules on target cell protection and natural killer cell specificity in transgenic mice.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    Eur J Immunol; 1996 Sep; 26(9):2127-32. PubMed ID: 8814257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.